GEN 4001

Economics of Biotechnology

Stanford University · UGRD · Fall 2026

1 section
Add to a schedule

Catalog description

Focuses on translation of promising research discovery into marketed drugs and the integration of scientific method, clinical needs assessment, clinical and regulatory strategy, market analysis, economic considerations, and the influence of the healthcare economic ecosystem necessary for successful translation. Explores the economic perspectives of various stakeholders--patients, providers, payers, biotechnology and pharmaceutical companies, FDA, and financial markets--and how they influence drug development.

Sections

Current meeting, instructor, credit, and enrollment details

Updated 4 hours ago

001

Availability not recently verified
Class #stanford-4001Fall 2026UGRD2 credits
Days & times
No scheduled meeting time
Meeting dates
Location
Instructor
Staff
Class numbers and section codes come from the registrar.
Spot missing or incorrect course data?